# Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients

Study · id `cardio:ct-nct01386853` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01386853](<https://clinicaltrials.gov/study/NCT01386853>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01386853

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT01386853. Randomized; quadruple masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2012-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT01386853, source copy `cardio:ctgov-nct01386853-2011-07-01`, retrieved 2026-10-31)
- Start date: 2011-07 (registry gives no type) (ClinicalTrials.gov record NCT01386853, source copy `cardio:ctgov-nct01386853-2011-07-01`, retrieved 2026-10-31)
- Primary completion: 2012-03 (anticipated) (ClinicalTrials.gov record NCT01386853, source copy `cardio:ctgov-nct01386853-2011-07-01`, retrieved 2026-10-31)
- Completion: 2012-07 (anticipated) (ClinicalTrials.gov record NCT01386853, source copy `cardio:ctgov-nct01386853-2011-07-01`, retrieved 2026-10-31)
- Countries: Taiwan (ClinicalTrials.gov record NCT01386853, source copy `cardio:ctgov-nct01386853-2011-07-01`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01386853-2011-07-01`, retrieved 2026-10-31)

## The registry's words

- Brief title: Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
- Condition: Hyperlipidemia
- Intervention (Drug): Pitavastatin
- Intervention (Drug): Atorvastatin
- Lead sponsor: Tai Tien Pharmaceuticals Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry intervention name matches this record: Pitavastatin (`cardio:pitavastatin`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Pitavastatin and Atorvastatin double-blind randomized comPArative study among hiGh-risk patients, including thOse with Type 2 diabetes mellitus, in Taiwan (PAPAGO-T Study) (`cardio:pubmed-24098467`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized study (`cardio:pubmed-25027585`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c4c4de46838a1066c1f249c28b0a95de98fe467f853a701a8990afd7e053f60d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
